Agilent Technologies (NYSE:A) Issues FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 6.180-6.210 for the period, compared to the consensus estimate of 6.060. The company issued revenue guidance of $7.5 billion-$7.5 billion, compared to the consensus revenue estimate of $7.4 billion. Agilent Technologies also updated its Q4 2026 guidance to 1.710-1.740 EPS.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on A shares. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. TD Cowen raised their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Morgan Stanley boosted their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Stock Performance

Shares of NYSE A traded up $0.39 during mid-day trading on Wednesday, hitting $155.16. The stock had a trading volume of 3,192,178 shares, compared to its average volume of 2,234,460. The company has a 50 day moving average of $138.55 and a two-hundred day moving average of $126.47. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $160.51. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The firm has a market cap of $43.82 billion, a PE ratio of 31.16, a PEG ratio of 2.71 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts predict that Agilent Technologies will post 6.05 EPS for the current fiscal year.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Quarterly results exceeded expectations: Agilent reported revenue of $1.88 billion, up 8.1% year over year and above the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of $1.49, while GAAP net income increased to $362 million, or $1.28 per share. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Profitability and cash flow improved: Operating profit rose 23.3% to $444 million, and operating cash flow climbed 43.4% to $519 million. The company ended the quarter with $1.8 billion in cash, supporting financial flexibility.
• Positive Sentiment: Full-year guidance was raised above consensus: Agilent forecast fiscal 2026 adjusted EPS of $6.18-$6.21, ahead of the $6.06 analyst consensus, and revenue of approximately $7.5 billion versus expectations of roughly $7.4 billion. Fourth-quarter EPS guidance of $1.71-$1.74 was in line to modestly above consensus. Agilent raises annual profit forecast on improving lab tools demand
• Neutral Sentiment: Institutional positioning was mixed: Recent filings showed 594 institutions adding shares and 550 reducing positions, indicating continued interest but no clear consensus among large investors.
• Neutral Sentiment: Valuation may limit further gains: The stock was trading near its 12-month high, while the median analyst price target was $155, roughly around the recent trading level. This suggests expectations for the improved outlook may already be reflected in the share price.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. State Street Corp lifted its position in Agilent Technologies by 1.9% during the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after purchasing an additional 241,029 shares during the period. Morgan Stanley grew its position in Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after purchasing an additional 692,202 shares during the period. Invesco Ltd. raised its stake in shares of Agilent Technologies by 32.0% during the 4th quarter. Invesco Ltd. now owns 2,590,715 shares of the medical research company’s stock valued at $352,519,000 after buying an additional 627,804 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after buying an additional 1,340,161 shares during the period. Finally, AQR Capital Management LLC boosted its stake in shares of Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares during the last quarter.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.